Live from the NIH registry
Studies recruiting near Des Moines right now
Top 25 of 230 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — West Des Moines, Iowa (5.2 mi)
· Sponsor: Medtronic
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3
Interventional 562 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Iowa Diabetes and Endocrinology Research Center /ID# 256750 — West Des Moines, Iowa (5.2 mi)
· Sponsor: AbbVie
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 2
Interventional 249 participants sought
Mission Cancer + Blood — Waukee, Iowa (14.5 mi)
· Sponsor: Loxo Oncology, Inc.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Integrated Clinical Trials Solution — West Des Moines, Iowa (5.2 mi)
· Sponsor: TriGemX Bio, Inc.
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
University of Iowa Health Care. ( Site 0057) — Waukee, Iowa (14.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Refractory Differentiated Thyroid Gland Carcinoma
Phase 3
Interventional 264 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
MercyOne Des Moines Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: Medtronic Cardiovascular
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Mercy Medical Center - Des Moines — Des Moines, Iowa (1.9 mi)
· Sponsor: NRG Oncology
Encore PFO Closure Device - The PerFOrm Trial
Patent Foramen Ovale, Cryptogenic Stroke
N/A
Interventional 500 participants sought
Mercy One Iowa Heart Center — West Des Moines, Iowa (5.2 mi)
· Sponsor: Encore Medical Inc.
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — West Des Moines, Iowa (5.2 mi)
· Sponsor: Akero Therapeutics, Inc
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Phase 3
Interventional 398 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: NRG Oncology
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Obesity, Overweight
Phase 3
Interventional 950 participants sought
Iowa Diabetes Research — West Des Moines, Iowa (5.2 mi)
· Sponsor: Amgen
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma
Phase 2
Interventional 156 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Iowa Methodist Medical Center — Des Moines, Iowa (1.9 mi)
· Sponsor: NRG Oncology
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 130 participants sought
Mission Blood and Cancer - MercyOne Cancer Center — Waukee, Iowa (14.5 mi)
· Sponsor: Hoffmann-La Roche
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Blank Children's Hospital — Des Moines, Iowa (1.9 mi)
· Sponsor: Children's Oncology Group
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 630 participants sought
Mission Cancer and Blood — Waukee, Iowa (14.5 mi)
· Sponsor: BeOne Medicines